Bruce Culleton - 13 Sep 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role: Chief Executive Officer, Director
Signature: /s/ Todd Girolamo, attorney in fact
Issuer symbol: PROK
Transactions as of: 13 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Sep 2024, 17:31:15 UTC
Previous filing: 05 Dec 2023
Next filing: 04 Mar 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PROK	Employee stock option (right to buy)	Award	$0	+500,000		$0.000000	500,000	13 Sep 2024	Class A Ordinary Shares	500,000	$1.69	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.

Content

This performance-based stock option was granted on December 3, 2023. On September 13, 2024, the Company's board of directors certified achievement of the performance goal at 100%. In addition to the achievement of the performance goal, the options are subject to time vesting requirements under which 25% vested on September 13, 2024 and the remaining 75% vests in equal installments of 125,000 shares on each of November 15, 2024, February 15, 2025 and May 15, 2025.